Related references
Note: Only part of the references are listed.Droplet-digital PCR reveals frequent mutations inTERTpromoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence ofMED12mutations
Kazutaka Otsuji et al.
BRITISH JOURNAL OF CANCER (2021)
BIRC3 and BIRC5: multi-faceted inhibitors in cancer
Raffaele Frazzi
CELL AND BIOSCIENCE (2021)
Validation of a Next-Generation Sequencing Assay Targeting RNA for the Multiplexed Detection of Fusion Transcripts and Oncogenic Isoforms
Robyn T. Sussman et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)
Droplet digital PCR is a sensitive tool for the detection of TP53 deletions and point mutations in chronic lymphocytic leukaemia
Raffaele Frazzi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
BIRC3 mutations in chronic lymphocytic leukemia - uncommon and unfavorable
Eugen Tausch et al.
HAEMATOLOGICA (2020)
Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial
Stuart J. Blakemore et al.
LEUKEMIA (2020)
Diagnostic Accuracy of Droplet Digital PCR and Amplification Refractory Mutation System PCR for Detecting EGFR Mutation in Cell-Free DNA of Lung Cancer: A Meta-Analysis
Caichen Li et al.
FRONTIERS IN ONCOLOGY (2020)
LRIG1 gene copy number analysis by ddPCR and correlations to clinical factors in breast cancer
Faraz Mahmood et al.
BMC CANCER (2020)
Somatic copy number alterations are associated with EGFR amplification and shortened survival in patients with primary glioblastoma
Lisandra Muoz-Hidalgoa et al.
NEOPLASIA (2020)
Novel ALK-specific mRNA in situ hybridization assay for non-small-cell lung carcinoma
Noriko Hirai et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020
Jim F. Huggett et al.
CLINICAL CHEMISTRY (2020)
Detection of Colorectal Cancer and Advanced Adenoma by Liquid Biopsy (Decalib Study): The ddPCR Challenge
Audelaure Junca et al.
CANCERS (2020)
Genomic alterations in chronic lymphocytic leukemia and their correlation with clinico-hematological parameters and disease progression
Vishrut K. Srinivasan et al.
BLOOD RESEARCH (2020)
FISH Analysis of TOP2A and HER-2 Aberrations in Female Breast Carcinoma on Archived Material: Egyptian NCI Experience
Omnia M. Badawy et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2019)
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease
Sara Raponi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Single-cell genetic analysis of clonal dynamics in colorectal adenomas indicates CDX2 gain as a predictor of recurrence
David Fiedler et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Expression of Circadian Clock Genes in Human Colorectal Cancer Tissues Using Droplet Digital PCR
Tugba Orhan et al.
CANCER INVESTIGATION (2019)
Clinical and Molecular Characterization of Adult Glioblastomas in Southern Brazil
Patricia Trevisan et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2019)
The impact of adjuvant radiotherapy on molecular prognostic markers in gliomas
Maciej Harat et al.
ONCOTARGETS AND THERAPY (2019)
Breast Cancer Subtype Classification Using 4-Plex Droplet Digital PCR
Wenwen Chen et al.
CLINICAL CHEMISTRY (2019)
Detection and Correlation of Single and Concomitant TP53, PTEN, and CDKN2A Alterations in Gliomas
Igor Andrade Pessoa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype
Cynthia Veenstra et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients
Marzia Del Re et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients
Beili Wang et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma
Andrew B. Lassman et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
HER2 double-equivocal breast cancer in Chinese patients: a high concordance of HER2 status between different blocks from the same tumor
Yuanyuan Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Fluorescence in Situ Hybridization (FISH) for Detecting Anaplastic Lymphoma Kinase (ALK) Rearrangement in Lung Cancer: Clinically Relevant Technical Aspects
Zhenya Tang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients
Zhouhuan Dong et al.
SCIENTIFIC REPORTS (2019)
Droplet digital PCR revealed high concordance between primary tumors and lymph node metastases in multiplex screening of KRAS mutations in colorectal cancer
Barbora Vanova et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2019)
Amplicons in breast cancers analyzed by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization
Akishi Ooi et al.
HUMAN PATHOLOGY (2019)
A Novel Multiplex Droplet Digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical Specimens
Miguel Alcaide et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2019)
Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation
Aoife J. McCarthy et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2019)
KRAS, NRAS, BRAF, HER2 and microsatellite instability in metastatic colorectal cancer - practical implications for the clinician
Vlad-Adrian Afrasanie et al.
RADIOLOGY AND ONCOLOGY (2019)
Ligation-dependent RT-PCR: a new specific and low-cost technique to detect ALK, ROS, and RET rearrangements in lung adenocarcinoma
Nicolas Piton et al.
LABORATORY INVESTIGATION (2018)
Biomarkers for ALK and ROS1 in Lung Cancer Immunohistochemistry and Fluorescent In Situ Hybridization
Peter P. Luk et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
Impact of PCR-based molecular analysis in daily diagnosis for the patient with gliomas
Kiyotaka Yokogami et al.
BRAIN TUMOR PATHOLOGY (2018)
GAEC1 mutations and copy number aberration is associated with biological aggressiveness of colorectal cancer
Katherine Ting-Wei Lee et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2018)
Optimization of the diagnosis of inherited colorectal cancer using NGS and capture of exonic and intronic sequences of panel genes
Stephanie Baert-Desurmont et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2018)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Clinical and Translational Implications of RET Rearrangements in Non-Small Cell Lung Cancer
Roberto Ferrara et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
EGFR gene copy number decreases during anti-EGFR antibody therapy in colorectal cancer
Eva-Maria Birkman et al.
HUMAN PATHOLOGY (2018)
Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues
Anchalee Tantiwetrueangdet et al.
MEDICAL ONCOLOGY (2018)
EGFR as a clinical marker in glioblastomas and other gliomas
Fadi S. Saadeh et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2018)
Bithalamic gliomas may be molecularly distinct from their unilateral high-grade counterparts
Alberto Broniscer et al.
BRAIN PATHOLOGY (2018)
Molecular Diagnostic and Prognostic Subtyping of Gliomas in Tunisian Population
Saoussen Trabelsi et al.
MOLECULAR NEUROBIOLOGY (2017)
EGFR Gene Amplification and KRAS Mutation Predict Response to Combination Targeted Therapy in Metastatic Colorectal Cancer
Sajid A. Khan et al.
PATHOLOGY & ONCOLOGY RESEARCH (2017)
Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma
Loyola V. Gressot et al.
ONCOTARGET (2017)
Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors
Frederic Fina et al.
ONCOTARGET (2017)
Lung Cancer Biomarkers
Pamela Villalobos et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2017)
Amplification of HER2 and TOP2A and deletion of TOP2A genes in a series of Taiwanese breast cancer
Jim-Ray Chen et al.
MEDICINE (2017)
Droplet digital PCR for quantification of ITGA6 in a stool mRNA assay for the detection of colorectal cancers
Elizabeth Herring et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Detection of somatic variants and EGFR mutations in cell-free DNA from non-small cell lung cancer patients by ultra-deep sequencing using the ion ampliseq cancer hotspot panel and droplet digital polymerase chain reaction
Jae Sook Sung et al.
ONCOTARGET (2017)
Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients
Thomas Sau-Yan Chan et al.
ONCOTARGET (2017)
Review of Clinical Next-Generation Sequencing
Sophia Yohe et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2017)
Initial Diagnosis of ALK-Positive Non-Small-Cell Lung Cancer Based on Analysis of ALK Status Utilizing Droplet Digital PCR
H. Louise Lund et al.
ANALYTICAL CHEMISTRY (2016)
A simplified approach for molecular classification of glioblastomas (GBMs): experience from a tertiary care center in India
Suvendu Purkait et al.
BRAIN TUMOR PATHOLOGY (2016)
A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia
Nisar A. Amin et al.
CLINICAL CANCER RESEARCH (2016)
Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Quantitative Detection and Resolution of BRAF V600 Status in Colorectal Cancer Using Droplet Digital PCR and a Novel Wild-Type Negative Assay
Roza Bidshahri et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2016)
Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma
Soma Ghasimi et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer
Helen Gogas et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
Siraj M. Ali et al.
ONCOLOGIST (2016)
Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population
Kristina Lagerstedt-Robinson et al.
ONCOLOGY REPORTS (2016)
Droplet digital PCR technology promises new applications and research areas
P. Manoj
MITOCHONDRIAL DNA PART A (2016)
Fluorescence In situ Hybridization: Cell-Based Genetic Diagnostic and Research Applications
Chenghua Cui et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Expanded RAS: Refining the Patient Population
Chloe E. Atreya et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma
Qiushi Wang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Fluorescence In Situ Hybridization, Immunohistochemistry, and Next-Generation Sequencing for Detection of EML4-ALK Rearrangement in Lung Cancer
Marina Pekar-Zlotin et al.
ONCOLOGIST (2015)
IDH1 mutation detection by droplet digital PCR in glioma
Jing Wang et al.
ONCOTARGET (2015)
Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials
M. J. Sorich et al.
ANNALS OF ONCOLOGY (2015)
Genetic Analysis of Diffuse High-Grade Astrocytomas in Infancy Defines a Novel Molecular Entity
Gerrit H. Gielen et al.
BRAIN PATHOLOGY (2015)
ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial
Matthew J. J. Rose-Zerilli et al.
HAEMATOLOGICA (2014)
Detection of Gene Rearrangements in Targeted Clinical Next-Generation Sequencing
Haley J. Abel et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
An International Interpretation Study Using the ALK IHC Antibody D5F3 and a Sensitive Detection Kit Demonstrates High Concordance between ALK IHC and ALK FISH and between Evaluators
Murry W. Wynes et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia
Tatjana Stankovic et al.
LEUKEMIA & LYMPHOMA (2014)
Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and Ultrasensitive Immunohistochemistry
Esther Conde et al.
PLOS ONE (2014)
Comprehensive chronic lymphocytic leukemia diagnostics by combined multiplex ligation dependent probe amplification (MLPA) and interphase fluorescence in situ hybridization (iFISH)
Eyad Alhourani et al.
MOLECULAR CYTOGENETICS (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
The Digital MIQE Guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments
Jim F. Huggett et al.
CLINICAL CHEMISTRY (2013)
Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients
Valerie Taly et al.
CLINICAL CHEMISTRY (2013)
Immunohistochemistry is a Reliable Screening Tool for Identification of ALK Rearrangement in Non-Small-Cell Lung Carcinoma and is Antibody Dependent
Chris M. J. Conklin et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization
Christina I. Selinger et al.
MODERN PATHOLOGY (2013)
ALK-Rearranged Lung Cancer in Chinese: A Comprehensive Assessment of Clinicopathology, IHC, FISH and RT-PCR
Yuan Li et al.
PLOS ONE (2013)
Contribution of MLPA to routine diagnostic testing of recurrent genomic aberrations in chronic lymphocytic leukemia
Lauren Veronese et al.
CANCER GENETICS (2013)
HER2 shedding and serum HER2 extracellular domain: Biology and clinical utility in breast cancer
Chantal Tse et al.
CANCER TREATMENT REVIEWS (2012)
The Use of Quantitative Real-Time Reverse Transcriptase PCR for 5′ and 3′ Portions of ALK Transcripts to Detect ALK Rearrangements in Lung Cancers
Rui Wang et al.
CLINICAL CANCER RESEARCH (2012)
Multiplex Ligation-dependent Probe Amplification (MLPA) in Tumor Diagnostics and Prognostics
Cornelia Homig-Holzel et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2012)
Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study
Andrea Sartore-Bianchi et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers
Stephen Yip et al.
JOURNAL OF PATHOLOGY (2012)
Dual IHC and FISH Testing for ALK Gene Rearrangement in Lung Adenocarcinomas in a Routine Practice A French Study
Anne McLeer-Florin et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients
Heae Surng Park et al.
LUNG CANCER (2012)
Histologic subtypes, immunohistochemistry, FISH or molecular screening for the accurate diagnosis of ALK-rearrangement in lung cancer: A comprehensive study of Caucasian non-smokers
Pierre-Alexandre Just et al.
LUNG CANCER (2012)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20052009
Therese A. Dolecek et al.
NEURO-ONCOLOGY (2012)
A quick and simple FISH protocol with hybridization-sensitive fluorescent linear oligodeoxynucleotide probes
Dan Ohtan Wang et al.
RNA (2012)
Assessment of HER2 Gene Status in Breast Carcinomas With Polysomy of Chromosome 17
Semir Vranic et al.
CANCER (2011)
BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma
Cynthia Hawkins et al.
CLINICAL CANCER RESEARCH (2011)
Screening of Anaplastic Lymphoma Kinase Rearrangement by Immunohistochemistry in Non-small Cell Lung Cancer Correlation with Fluorescence In Situ Hybridization
Jin Ho Paik et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Correlation of IHC and FISH for ALK Gene Rearrangement in Non-small Cell Lung Carcinoma IHC Score Algorithm for FISH
Eunhee S. Yi et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
New driver mutations in non-small-cell lung cancer
William Pao et al.
LANCET ONCOLOGY (2011)
Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness
Esther H. Lips et al.
BREAST CANCER RESEARCH (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique
Brian V. Balgobind et al.
EUROPEAN JOURNAL OF CANCER (2010)
Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma
Ryu Jokoji et al.
JOURNAL OF CLINICAL PATHOLOGY (2010)
Multiplex Ligation-Dependent Probe Amplification Versus Multiprobe Fluorescence in Situ Hybridization To Detect Genomic Aberrations in Chronic Lymphocytic Leukemia A Tertiary Center Experience
Eiman A. Al Zaabi et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
In situ detection and genotyping of individual mRNA molecules
Chatarina Larsson et al.
NATURE METHODS (2010)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Detection, Analysis and Clinical Validation of Chromosomal Aberrations by Multiplex Ligation-Dependent Probe Amplification in Chronic Leukemia
Adam Abdool et al.
PLOS ONE (2010)
Duplication of 7q34 in Pediatric Low-Grade Astrocytomas Detected by High-Density Single-Nucleotide Polymorphism-Based Genotype Arrays Results in a Novel BRAF Fusion Gene
Angela J. Sievert et al.
BRAIN PATHOLOGY (2009)
Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population
Scott J. Rodig et al.
CLINICAL CANCER RESEARCH (2009)
Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Who Harbor EML4-ALK
Alice T. Shaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
Michael Weller et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis
Caterina Marchio et al.
JOURNAL OF PATHOLOGY (2009)
EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset
Kentaro Inamura et al.
MODERN PATHOLOGY (2009)
Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event
I-Tien Yeh et al.
MODERN PATHOLOGY (2009)
EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors
Li Li et al.
NEURO-ONCOLOGY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis
Haihao Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins
David S. Ziegler et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
An integrated microfluidic chip for chromosome enumeration using fluorescence in situ hybridization
Vincent J. Sieben et al.
LAB ON A CHIP (2008)
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents:: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
Helena Linardou et al.
LANCET ONCOLOGY (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Fluorescence in situ hybridization in diagnostic cytolog
Kevin C. Halling et al.
HUMAN PATHOLOGY (2007)
Characterization of the amplicon on chromosomal segment 4q12 in glioblastoma multiforme
Nikola Holtkamp et al.
NEURO-ONCOLOGY (2007)
HER2, TOP2A, CCND1, EGFR and c-MYC oncogene amplification in colorectal cancer
Khawla Al-Kuraya et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications
Jean L. Nakamura
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Multiplex ligation-dependent probe amplification - A diagnostic tool for simultaneous identification of different genetic markers in glial tumors
Judith Jeuken et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer
A Lièvre et al.
CANCER RESEARCH (2006)
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia
A Kröber et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Preclinical validation of fluorescence in situ hybridization assays for clinical practice
AE Wiktor et al.
GENETICS IN MEDICINE (2006)
Molecular stratification of diagnostically challenging high-grade gliomas composed of small cells:: The utility of fluorescence in situ hybridization
A Korshunov et al.
CLINICAL CANCER RESEARCH (2004)
LNA-modified oligonucleotides are highly efficient as FISH probes
A Silahtaroglu et al.
CYTOGENETIC AND GENOME RESEARCH (2004)
Clinical implications of advanced molecular cytogenetics in cancer
SD Mundle et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2004)
Single-molecule PCR using water-in-oil emulsion
M Nakano et al.
JOURNAL OF BIOTECHNOLOGY (2003)
Single-cell gene expression profiling
JM Levsky et al.
SCIENCE (2002)
Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification
JP Schouten et al.
NUCLEIC ACIDS RESEARCH (2002)
Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme
JA Kraus et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
JS Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
